Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia
Author
Source
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-10-01
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Trigeminal neuralgia (TN) is a clinical condition characterized by paroxysmal attacks of severe and electric shock-like pain along the distribution of one or more branches of the trigeminal nerve.
Various medicinal or surgical modalities have been employed in the past with variable success.
Newer methods were tried in search of permanent cure or long-lasting pain relief.
The purpose of this paper is to present the review of the literature regarding the use of botulinum toxin type-A (BTX-A) in the management of trigeminal neuralgia.
American Psychological Association (APA)
Verma, Gaurav. 2013. Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia. Pain Research and Treatment،Vol. 2013, no. 2013, pp.1-6.
https://search.emarefa.net/detail/BIM-501631
Modern Language Association (MLA)
Verma, Gaurav. Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia. Pain Research and Treatment No. 2013 (2013), pp.1-6.
https://search.emarefa.net/detail/BIM-501631
American Medical Association (AMA)
Verma, Gaurav. Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia. Pain Research and Treatment. 2013. Vol. 2013, no. 2013, pp.1-6.
https://search.emarefa.net/detail/BIM-501631
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-501631
